First Hawaiian Bank Increases Holding in Applied Materials (AMAT); C M Bidwell & Associates LTD Holds Stake in Alexion Pharmaceuticals (ALXN)

Applied Materials, Inc. (NASDAQ:AMAT) Logo

C M Bidwell & Associates Ltd increased its stake in Alexion Pharmaceuticals (ALXN) by 1264% based on its latest 2018Q4 regulatory filing with the SEC. C M Bidwell & Associates Ltd bought 3,160 shares as the company’s stock rose 10.78% with the market. The institutional investor held 3,410 shares of the health care company at the end of 2018Q4, valued at $332,000, up from 250 at the end of the previous reported quarter. C M Bidwell & Associates Ltd who had been investing in Alexion Pharmaceuticals for a number of months, seems to be bullish on the $28.03 billion market cap company. The stock decreased 8.76% or $11.99 during the last trading session, reaching $124.95. About 1.78M shares traded or 18.67% up from the average. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has risen 18.22% since April 17, 2018 and is uptrending. It has outperformed by 13.85% the S&P500. Some Historical ALXN News: 11/04/2018 – ALEXION PHARMACEUTICALS INC ALXN.O SAYS ALEXION WILL ACQUIRE WILSON THERAPEUTICS THROUGH A TENDER OFFER; 26/04/2018 – Alexion Pharmaceuticals 1Q EPS $1.11; 20/04/2018 – Alexion: No Compulsory License of Soliris(R) Was Requested or Granted in Brazil; 15/03/2018 – ALEXION PHARMACEUTICALS INC – SAFETY PROFILE OF ALXN1210 CONSISTENT WITH THAT SEEN FOR SOLIRIS; 11/04/2018 – Alexion: Wilson’s WTX101 is in Phase 3 Development as a Novel Treatment for a Rare, Genetic, and Chronic Copper-Mediated Liver Disorder; 11/04/2018 – Alexion Intends to Finance the Acquisition of Wilson Through Cash on Hand; 23/04/2018 – Alexion Pharmaceuticals Inc expected to post earnings of $1.50 a share – Earnings Preview; 15/03/2018 – Alexion Pharmaceuticals: Safety Profile of ALXN1210 Consistent With That Seen for Soliris; 15/03/2018 – ALEXION PHARMACEUTICALS INC ALXN.O : CREDIT SUISSE RAISES TARGET PRICE TO $149 FROM $147; 15/03/2018 Alexion Announces Positive Top-Line Results Showing Successful Phase 3 Clinical Study of ALXN1210 in Complement Inhibitor

First Hawaiian Bank increased its stake in Applied Materials (AMAT) by 239.43% based on its latest 2018Q4 regulatory filing with the SEC. First Hawaiian Bank bought 18,094 shares as the company’s stock rose 5.31% with the market. The institutional investor held 25,651 shares of the technology company at the end of 2018Q4, valued at $839,000, up from 7,557 at the end of the previous reported quarter. First Hawaiian Bank who had been investing in Applied Materials for a number of months, seems to be bullish on the $41.69 billion market cap company. The stock increased 0.43% or $0.19 during the last trading session, reaching $43.91. About 5.14M shares traded. Applied Materials, Inc. (NASDAQ:AMAT) has declined 31.52% since April 17, 2018 and is downtrending. It has underperformed by 35.89% the S&P500. Some Historical AMAT News: 26/04/2018 – ADVISORY-Alert on Applied Materials CEO commenting on blockchain technology withdrawn; 17/05/2018 – Chip gear maker Applied Materials reports 29 pct rise in revenue; 17/05/2018 – Applied Materials 2Q Net $1.13B; 17/05/2018 – Applied Materials Sags on Weaker Revenue Outlook — Barron’s Blog; 17/05/2018 – APPLIED MATERIALS INC – QUARTERLY REVENUE OF $4.57 BLN, UP 29 PERCENT YEAR OVER YEAR; 14/05/2018 – APPLIED MATERIALS INC AMAT.O : CITIGROUP RAISES TARGET PRICE TO $78 FROM $70; 17/05/2018 – APPLIED MATERIALS CEO SPEAKING ON CONFERENCE CALL; 17/05/2018 – Applied Materials 2Q EPS $1.09; 18/05/2018 – Tech Today: Square Unzettled, Debating AMAT, Google’s 60 Minutes — Barron’s Blog; 16/05/2018 – Applied Materials at AllianceBernstein Conference May 30

More notable recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: 247Wallst.com which released: “Big Biotechs Confound Short Sellers – 24/7 Wall St.” on April 10, 2019, also Nasdaq.com with their article: “4 Blockbuster Drug Launches to Watch in 2019 – Nasdaq” published on March 24, 2019, Seekingalpha.com published: “UBS likes Gilead in premarket analyst action – Seeking Alpha” on April 10, 2019. More interesting news about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) were released by: Seekingalpha.com and their article: “Achillion Pharmaceuticals: The Promise Of Alternative Pathway Inhibition – Seeking Alpha” published on March 20, 2019 as well as Nasdaq.com‘s news article titled: “Ra Pharmaceuticals Closes End-of-Phase 2 Interaction with FDA – Nasdaq” with publication date: April 10, 2019.

Investors sentiment increased to 1.11 in 2018 Q4. Its up 0.07, from 1.04 in 2018Q3. It increased, as 44 investors sold ALXN shares while 167 reduced holdings. 76 funds opened positions while 159 raised stakes. 206.79 million shares or 1.74% more from 203.25 million shares in 2018Q3 were reported. 79,537 were accumulated by Pdt Prtnrs Llc. Riverhead Cap Management invested 0.03% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Ubs Asset Mngmt Americas has 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Fred Alger owns 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 5,706 shares. Metropolitan Life Insur Com reported 40,887 shares stake. C World Wide Group Holding A S accumulated 51,600 shares. Gamco Investors Et Al holds 6,000 shares or 0% of its portfolio. Sphera Funds Mngmt Ltd holds 168,100 shares. Profund Advsrs Ltd Liability Company accumulated 0.45% or 75,315 shares. Moreover, Virginia Retirement System Et Al has 0.11% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Qs Invsts Lc, New York-based fund reported 9,522 shares. Tealwood Asset Mngmt holds 0.46% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 10,061 shares. Price T Rowe Assocs Incorporated Md holds 17.67M shares or 0.29% of its portfolio. Investment Management Of Virginia Lc reported 5,392 shares or 0.14% of all its holdings. Putnam Limited Com owns 2,105 shares for 0% of their portfolio.

C M Bidwell & Associates Ltd, which manages about $447.15 million and $92.17M US Long portfolio, decreased its stake in Northrop Gruman (NYSE:NOC) by 1,315 shares to 12 shares, valued at $3,000 in 2018Q4, according to the filing. It also reduced its holding in Progressive Corp Ohio (NYSE:PGR) by 7,790 shares in the quarter, leaving it with 8,105 shares, and cut its stake in Apple Inc (NASDAQ:AAPL).

Since November 28, 2018, it had 0 buys, and 2 selling transactions for $618,666 activity. 3,244 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares with value of $310,937 were sold by HANTSON LUDWIG.

More notable recent Applied Materials, Inc. (NASDAQ:AMAT) news were published by: Nasdaq.com which released: “Nasdaq 100 Movers: JBHT, WDC – Nasdaq” on April 16, 2019, also Nasdaq.com with their article: “Applied Materials, Inc. (AMAT) Ex-Dividend Date Scheduled for February 20, 2019 – Nasdaq” published on February 19, 2019, Nasdaq.com published: “Applied Materials (AMAT) Shares Cross Above 200 DMA – Nasdaq” on March 15, 2019. More interesting news about Applied Materials, Inc. (NASDAQ:AMAT) were released by: Nasdaq.com and their article: “SOXX, QCOM, AMD, AMAT: Large Outflows Detected at ETF – Nasdaq” published on March 22, 2019 as well as Nasdaq.com‘s news article titled: “Why Is Applied Materials (AMAT) Down 6.8% Since Last Earnings Report? – Nasdaq” with publication date: December 15, 2018.

Investors sentiment decreased to 0.79 in Q4 2018. Its down 0.01, from 0.8 in 2018Q3. It fall, as 100 investors sold AMAT shares while 289 reduced holdings. 96 funds opened positions while 212 raised stakes. 717.25 million shares or 0.75% less from 722.69 million shares in 2018Q3 were reported. Bryn Mawr reported 11,618 shares. Ontario Teachers Pension Plan Board holds 64,723 shares or 0.05% of its portfolio. Dekabank Deutsche Girozentrale has 321,053 shares for 0.07% of their portfolio. Point72 Asset Mngmt LP accumulated 1.48 million shares. Princeton Portfolio Strategies Limited Liability Corp invested in 0.07% or 6,500 shares. Comerica National Bank stated it has 193,816 shares or 0.06% of all its holdings. Advsrs Asset Mgmt holds 69,820 shares or 0.05% of its portfolio. Nuveen Asset Management Lc has 376,896 shares for 0.08% of their portfolio. Zebra Mgmt Lc holds 0.61% of its portfolio in Applied Materials, Inc. (NASDAQ:AMAT) for 30,236 shares. Legg Mason Asset Mgmt (Japan) Limited stated it has 22,200 shares or 0.91% of all its holdings. Bragg Financial holds 0.74% or 149,401 shares in its portfolio. Bremer Tru Natl Association holds 0.04% or 5,427 shares in its portfolio. Virginia-based Wilbanks Smith & Thomas Asset Mngmt Lc has invested 0.01% in Applied Materials, Inc. (NASDAQ:AMAT). Fil Ltd holds 0.09% of its portfolio in Applied Materials, Inc. (NASDAQ:AMAT) for 1.58M shares. Williams Jones & Associate Limited Liability Com reported 0.01% in Applied Materials, Inc. (NASDAQ:AMAT).

First Hawaiian Bank, which manages about $1.67 billion US Long portfolio, decreased its stake in Bwx Technologies Inc by 8,851 shares to 9,431 shares, valued at $361,000 in 2018Q4, according to the filing. It also reduced its holding in Lockheed Martin Corp (NYSE:LMT) by 2,463 shares in the quarter, leaving it with 3,309 shares, and cut its stake in L3 Technologies Inc.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart